drugset / Trial / NCT02144389

Arachidonic Acid Treatment Against Schistosomiasis Infection in Children

NCT02144389

RandomizedParallel-groupTriple-blindTreatment

Summary

Randomized Controlled Trial: The investigational materials used in this trial were administered to subjects each day by trained clinicians. Primary Objectives: * assess the effect of dietary supplementation with arachidonic acid on the cure rates for Schistosomiasis mansoni with and without concomitant treatment with praziquantel. * assess the safety of dietary supplementation using arachidonic acid in children with clinically confirmed schistosomiasis mansoni infection. Secondary objective: * to measure changes in total phospholipids in plasma.

Timeline

Start
2013-01
Primary completion
2013-07
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Praziquantel Small molecule 40 mg/kg Oral